Advertisement

Liver Disease pp 255-277 | Cite as

General Overview of the Liver Transplant Patient

  • Anjana PillaiEmail author
  • Thomas Couri
Chapter

Abstract

Liver transplantation (LT) is the only cure for end-stage liver disease. Almost 6000 liver transplants were performed in 2013, and more than 15,000 patients are on the liver transplant waiting list in the United States. Patient outcomes continue to improve with the majority of patients living more than 10 years after LT. With this increased life expectancy, attention to the long-term care of liver transplant recipients is paramount. In this chapter, we discuss the common medical conditions, the immunosuppression and antimicrobial prophylaxis regimens, and the approach to abnormal liver chemistry tests in the LT recipient.

Keywords

Liver transplant Abnormal liver chemistry tests Immunosuppression 

Further Reading

  1. 1.
    Banff Working Group. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology. 2006;44(2):489–501.  https://doi.org/10.1002/hep.21280.CrossRefGoogle Scholar
  2. 2.
    Cheung A, Levitsky J. Follow-up of the post-liver transplantation patient. Clin Liver Dis. 2017;21(4):793–813.  https://doi.org/10.1016/j.cld.2017.06.006.CrossRefPubMedGoogle Scholar
  3. 3.
    Demetris AJ, Murase N, Lee RG, et al. Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant. 1997;2(2):27–44.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Liu LU, Schiano TD. Long-term care of the liver transplant recipient. Clin Liver Dis. 2007;11(2):397–416.  https://doi.org/10.1016/j.cld.2007.04.003.CrossRefPubMedGoogle Scholar
  5. 5.
    Marino FYCNSTGMMWIR. Fever in liver transplant recipients: changing spectrum of etiologic agents. Clin Infect Dis. 1998;26(1):59–65.CrossRefGoogle Scholar
  6. 6.
    Pillai AA. Management of de novo malignancies after liver transplantation. Transplant Rev. 2015;29(1):38–41.  https://doi.org/10.1016/j.trre.2014.11.002.CrossRefGoogle Scholar
  7. 7.
    Verdonk RC, Buis CI, Porte RJ, Haagsma EB. Biliary complications after liver transplantation: a review. Scand J Gastroenterol Suppl. 2006;243:89–101.  https://doi.org/10.1080/00365520600664375.CrossRefGoogle Scholar
  8. 8.
    Watt KDS, Charlton MR. Metabolic syndrome and liver transplantation: a review and guide to management. J Hepatol. 2010;53(1):199–206.  https://doi.org/10.1016/j.jhep.2010.01.040.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Division of Gastroenterology, Hepatology, and NutritionUniversity of Chicago Medical CenterChicagoUSA
  2. 2.Department of Internal MedicineUniversity of Chicago Medical CenterChicagoUSA

Personalised recommendations